Literature DB >> 8389197

Potassium currents and effects of vitamin D-3 metabolites and cyclic GMP in rat osteoblastic cells.

D Chesnoy-Marchais1, J Fritsch.   

Abstract

A K+ current (IK1), activated by depolarization above -20 mV, showing voltage-dependent inactivation within a few seconds and reduced by 40% by 1 mM TEA, was observed in all cells. In a few cells, we also observed a progressive K(+)-current increase during cell dialysis. The developing current (IK2) was not sensitive to 1 mM TEA and did not inactivate. It was detectable over the whole voltage range and slowly increased during 10 s depolarizations. 1,25-(OH)2D3 and 24,25-(OH)2D3 did not affect IK1, but induced a small K(+)-current increase in some cells showing no IK2. This effect was not mimicked by cyclic GMP analogs which, on the contrary, induced a K(+)-current decrease. 24,25-(OH)2D3 (even at 10(-11)M, but not 1,25-(OH)2D3, strongly reduced IK2. The results further document the diversity of voltage-gated currents of osteoblastic cells, confirm the existence of immediate effects of vitamin D-3 metabolites, which are independent of classical 1,25-(OH)2D3 receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389197     DOI: 10.1016/0005-2736(93)90135-m

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Concentration-dependent modulations of potassium and calcium currents of rat osteoblastic cells by arachidonic acid.

Authors:  D Chesnoy-Marchais; J Fritsch
Journal:  J Membr Biol       Date:  1994-03       Impact factor: 1.843

2.  Activation of hyperpolarization and atypical osmosensitivity of a Cl- current in rat osteoblastic cells.

Authors:  D Chesnoy-Marchais; J Fritsch
Journal:  J Membr Biol       Date:  1994-06       Impact factor: 1.843

3.  Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor.

Authors:  Laura P Zanello; Anthony W Norman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-02       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.